AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32912727 — intervention group
Group type: COMPARATOR
Intervention: Control group (reviewed module afterward)
Number of subjects: 63
Study 35191924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual dexmedetomidine 180 μg
Number of subjects: 380
Study 35191924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual dexmedetomidine 120 μg
Number of subjects: 380
Study 35191924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study 35191924 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 380
Study 34025637 — intervention group
Group type: EXPERIMENTAL
Intervention: CAR-T-allo-HSCT
Number of subjects: 105
Study 34025637 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy-allo-HSCT
Number of subjects: 105
Study 32890299 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative wound infiltration with local anesthetics, morphine sulfate, epinephrine, and nonsteroidal anti-inflammatory drugs; postoperative patient-controlled analgesia (PCA).
Number of subjects: 49
Study 32890299 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative wound infiltration with multimodal drugs; postoperative patient-controlled analgesia (PCA).
Number of subjects: 49
Study 32890299 — intervention group
Group type: COMPARATOR
Intervention: Control group received only PCA postoperatively.
Number of subjects: 49
Study 33978602 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal estrogen (VE)
Number of subjects: 17
Study 34678128 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide at 45 μg/kg ideal body weight/h (iNO45)
Number of subjects: 44
Study 34678128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32033612 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective lung ventilation (VT set at 6 ml/kg of predicted body weight with individualized PEEP during dura opening)
Number of subjects: 54
Study 32033612 — intervention group
Group type: COMPARATOR
Intervention: Control group (VT set at 8 ml/kg of predicted body weight, no PEEP or recruitment maneuvers)
Number of subjects: 54
Study 32033612 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective lung ventilation
Number of subjects: 54
Study 32033612 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 32935593 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCIA 601P IOL (non-constant aberration)
Number of subjects: 77
Study 32935593 — intervention group
Group type: EXPERIMENTAL
Intervention: CT ASPHINA 509M IOL (spherical aberration -0.18μm)
Number of subjects: 77
Study 32935593 — intervention group
Group type: EXPERIMENTAL
Intervention: AMO Tecnis ZCB00 IOL (spherical aberration -0.27μm)
Number of subjects: 77
Study 32935593 — intervention group
Group type: COMPARATOR
Intervention: Higher order aberration (all groups)
Number of subjects: 77
Study 32935593 — intervention group
Group type: COMPARATOR
Intervention: Contrast sensitivity (all groups)
Number of subjects: 77
Study 32935593 — intervention group
Group type: COMPARATOR
Intervention: IOL decentration (all groups)
Number of subjects: 77
Study 32935593 — intervention group
Group type: COMPARATOR
Intervention: IOL tilt (all groups)
Number of subjects: 77
Study 33034651 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid 'Go to the Hospital or Stay Here?'
Number of subjects: 0
Study 33034651 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 36327047 — intervention group
Group type: EXPERIMENTAL
Intervention: AB+AA (auricular acupoint bloodletting plus auricular acupressure)
Number of subjects: 74
Study 36327047 — intervention group
Group type: COMPARATOR
Intervention: AA (auricular acupressure)
Number of subjects: 74
Study 33466131 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 200
Study 33466131 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid injection
Number of subjects: 200
Study 35324339 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular group (0.4mg/kg/day of methylprednisolone orally for 10 days)
Number of subjects: 35
Study 35324339 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering group (0.4mg/kg/day of methylprednisolone orally for 7 days, followed by progressive reduction of 8 mg per week for 3 weeks)
Number of subjects: 35
Study 35324339 — intervention group
Group type: COMPARATOR
Intervention: Regular group
Number of subjects: 35
Study 35324339 — intervention group
Group type: COMPARATOR
Intervention: Tapering group
Number of subjects: 35
Study 33263202 — intervention group
Group type: EXPERIMENTAL
Intervention: Exact sign test
Number of subjects: 0
Study 33263202 — intervention group
Group type: EXPERIMENTAL
Intervention: McNemar-type test
Number of subjects: 0
Study 35289004 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy-based intervention
Number of subjects: 237
Study 34565133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Isotonic Contraction Group (CIC)
Number of subjects: 35
Study 34565133 — intervention group
Group type: COMPARATOR
Intervention: Conventional Physiotherapy Group
Number of subjects: 35
Study 34565133 — intervention group
Group type: COMPARATOR
Intervention: Repeated Stretching Group
Number of subjects: 35
Study 36377904 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Cost Awareness Program (real-time cost awareness software)
Number of subjects: 322
Study 36377904 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 322
Study 32111230 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% albumin solution
Number of subjects: 1386
Study 32111230 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate solution
Number of subjects: 1386
Study 35023557 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Benzoate (250-1500 mg/d)
Number of subjects: 117
Study 35023557 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (25-150 mg/d)
Number of subjects: 117
Study 35023557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 34859831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aura intervention
Number of subjects: 160
Study 34859831 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 34962665 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + diode laser (0.80W power, 940 nm wavelength, 0.80J/s energy level)
Number of subjects: 40
Study 34962665 — intervention group
Group type: COMPARATOR
Intervention: Only SRP group
Number of subjects: 40
Study 32537732 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix rhythm therapy (MRT) combined with Bobath therapy (BT)
Number of subjects: 30
Study 32537732 — intervention group
Group type: COMPARATOR
Intervention: Bobath therapy (BT)
Number of subjects: 30
Study 35509085 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral ferrous sulfate (60 mg of elemental iron) daily for 12 weeks
Number of subjects: 52
Study 35509085 — intervention group
Group type: COMPARATOR
Intervention: 300 mg oral ferrous sulfate (60 mg of elemental iron) every other day for 12 weeks
Number of subjects: 52
Study 33446152 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 82
Study 33446152 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 82
Study 33234798 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic total mesorectal excision with Denonvilliers' fascia preservation (Exp-group, n = 123)
Number of subjects: 253
Study 35175934 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-controlled expiration (FLEX) ventilation
Number of subjects: 8
Study 34294510 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-targeted biopsy
Number of subjects: 999
Study 35332040 — intervention group
Group type: EXPERIMENTAL
Intervention: HN001 capsules
Number of subjects: 153
Study 35332040 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 153
Study 35332040 — intervention group
Group type: EXPERIMENTAL
Intervention: OBG cereal
Number of subjects: 153
Study 35332040 — intervention group
Group type: COMPARATOR
Intervention: Control cereal
Number of subjects: 153
Study 35332040 — intervention group
Group type: COMPARATOR
Intervention: HN001 vs Placebo
Number of subjects: 153
Study 35332040 — intervention group
Group type: COMPARATOR
Intervention: OBG vs Control
Number of subjects: 153
Study 35332040 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 153
Study 32526362 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 961
Study 32526362 — intervention group
Group type: COMPARATOR
Intervention: Curative treatment
Number of subjects: 961
Study 32526362 — intervention group
Group type: COMPARATOR
Intervention: Active UIA treatment
Number of subjects: 961
Study 32526362 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment or surgical treatment
Number of subjects: 961
Study 32526362 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall management
Number of subjects: 961
Study 32526362 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization duration
Number of subjects: 961
Study 32526362 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge location
Number of subjects: 961
Study 32526362 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid hemorrhage incidence
Number of subjects: 961
Study 34994794 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic aquatic exercise
Number of subjects: 113
Study 34994794 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy modalities
Number of subjects: 113
Study 32384727 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-day bamboo forest therapy session
Number of subjects: 120
Study 32384727 — intervention group
Group type: COMPARATOR
Intervention: Bamboo forest sites (YA, YB, DJY)
Number of subjects: 120
Study 32635877 — intervention group
Group type: COMPARATOR
Intervention: Closed extracorporeal membrane oxygenation circuits (wet primed) inoculated with Escherichia coli
Number of subjects: 0
Study 32635877 — intervention group
Group type: EXPERIMENTAL
Intervention: Open circuits (dry setup)
Number of subjects: 0
Study 32635877 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed circuits (dry setup)
Number of subjects: 0
Study 32635877 — intervention group
Group type: EXPERIMENTAL
Intervention: Open, wet-primed circuits
Number of subjects: 0
Study 32635877 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed, wet-primed circuits
Number of subjects: 0
Study 32635877 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-primed circuits
Number of subjects: 0
Study 35139822 — intervention group
Group type: EXPERIMENTAL
Intervention: C + ECD group sessions
Number of subjects: 75
Study 35139822 — intervention group
Group type: EXPERIMENTAL
Intervention: T + enhanced play materials package
Number of subjects: 75
Study 35139822 — intervention group
Group type: COMPARATOR
Intervention: Status quo (community-based health and nutrition program)
Number of subjects: 75
Study 33647776 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangqi decoction (HQD) components including astragaloside IV, cycloastragenol, glycyrrhizic acid, glycyrrhetinic acid, liquiritigenin, and isoliquiritigenin
Number of subjects: 0
Study 33647776 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangqi decoction (HQD) components including cycloastragenol, calycosin‐7‐O‐β‐D‐glucoside, formononetin, glycyrrhetinic acid, liquiritin, and isoliquiritin
Number of subjects: 0
Study 33647776 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangqi decoction (HQD) components including calycosin, liquiritigenin, isoliquiritigenin, cycloastragenol, and glycyrrhetinic
Number of subjects: 0
Study 33647776 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component combination of HQD (MCHD)
Number of subjects: 0
Study 32149887 — intervention group
Group type: EXPERIMENTAL
Intervention: MJ + SJ (barbell bench press plus lying barbell triceps press)
Number of subjects: 43
Study 32149887 — intervention group
Group type: EXPERIMENTAL
Intervention: SJ + MJ (lying barbell triceps press plus barbell bench press)
Number of subjects: 43
Study 32149887 — intervention group
Group type: EXPERIMENTAL
Intervention: MJ (barbell bench press)
Number of subjects: 43
Study 32149887 — intervention group
Group type: COMPARATOR
Intervention: SJ (lying barbell triceps press)
Number of subjects: 43
Study 36068191 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable group (UG) functional exercises for 8 weeks, 3 days/week, 1 hour/day
Number of subjects: 34
Study 36068191 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable group (SG) functional exercises for 8 weeks, 3 days/week, 1 hour/day
Number of subjects: 34
Study 36068191 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG); no training
Number of subjects: 34
Study 33285650 — intervention group
Group type: EXPERIMENTAL
Intervention: hMHS‐rTMS
Number of subjects: 10
Study 33285650 — intervention group
Group type: EXPERIMENTAL
Intervention: HK‐rTMS
Number of subjects: 10
Study 33285650 — intervention group
Group type: COMPARATOR
Intervention: Sham‐rTMS
Number of subjects: 10
Study 33118309 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin users with continuous glucose monitoring (CGM)
Number of subjects: 173
Study 33118309 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded CGM
Number of subjects: 173
Study 33118309 — intervention group
Group type: COMPARATOR
Intervention: Real-time CGM
Number of subjects: 173
Study 35202890 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.2 mg
Number of subjects: 225
Study 35202890 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.1 mg
Number of subjects: 225
Study 35202890 — intervention group
Group type: COMPARATOR
Intervention: Laser
Number of subjects: 225
Study 33492175 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogstate Brief Battery (CBB) performed to the best of their ability
Number of subjects: 64
Study 33492175 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogstate Brief Battery (CBB) simulated cognitive impairment
Number of subjects: 64
Study 33492175 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection task of the CBB
Number of subjects: 64
Study 33492175 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants (control group)
Number of subjects: 64
Study 34166289 — intervention group
Group type: EXPERIMENTAL
Intervention: Model predicting impending ICU hypoglycemia using 61 physiologic markers.
Number of subjects: 11847
Study 34166289 — intervention group
Group type: EXPERIMENTAL
Intervention: External validation of the model in the Medical Information Mart for Intensive Care III dataset.
Number of subjects: 11847
Study 34925044 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgolide® treatment with IV rt‐PA
Number of subjects: 1113
Study 34925044 — intervention group
Group type: COMPARATOR
Intervention: Control group (IV rt‐PA only)
Number of subjects: 1113
Study 34925044 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgolide® treatment with IV rt‐PA after propensity score matching
Number of subjects: 1113
Study 32556356 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group
Number of subjects: 88
Study 32556356 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 88
Study 36692224 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led deprescribing intervention
Number of subjects: 363
Study 36692224 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 363
Study 32948867 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (WP) hydrolysate
Number of subjects: 73
Study 32948867 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (WP) combined with low-fiber (LoFi; 10 g dietary fiber/day)
Number of subjects: 73
Study 32948867 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (MD)
Number of subjects: 73
Study 32948867 — intervention group
Group type: COMPARATOR
Intervention: Whey protein (WP) and dietary fiber from wheat bran
Number of subjects: 73
Study 32854834 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip plus GDMT
Number of subjects: 614
Study 32854834 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 614
Study 35412478 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal contact lenses (MFCLs)
Number of subjects: 11
Study 35412478 — intervention group
Group type: COMPARATOR
Intervention: Progressive addition lenses for general purpose (GP-PALs)
Number of subjects: 11
Study 33524320 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty
Number of subjects: 192
Study 33524320 — intervention group
Group type: COMPARATOR
Intervention: Sham/control
Number of subjects: 192
Study 32418856 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) administered intraoperatively after open arthrolysis
Number of subjects: 61
Study 32418856 — intervention group
Group type: COMPARATOR
Intervention: Saline administration (control group)
Number of subjects: 61
Study 35458181 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry supplementation
Number of subjects: 0
Study 33760010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrawound vancomycin powder (1000 mg)
Number of subjects: 980
Study 33760010 — intervention group
Group type: COMPARATOR
Intervention: Standard infection prevention protocol without vancomycin
Number of subjects: 980
Study 32337268 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40
Study 32337268 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 40
Study 35982481 — intervention group
Group type: EXPERIMENTAL
Intervention: Developed algorithm for sleep/wake states using FS-760
Number of subjects: 65
Study 35982481 — intervention group
Group type: COMPARATOR
Intervention: Adult algorithm applied to children's activity
Number of subjects: 65
Study 35982481 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression analysis
Number of subjects: 65
Study 32145206 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity pulsed ultrasound (LIPUS) stimulation (1.5 MHz, 30 mW/cm2) for 20 minutes daily on postoperative days 4, 8, 14, and 20
Number of subjects: 40
Study 32145206 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity pulsed ultrasound (LIPUS) stimulation
Number of subjects: 40
Study 32145206 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LIPUS stimulation)
Number of subjects: 40
Study 34387520 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 60,000 IU weekly for 8 weeks
Number of subjects: 100
Study 34387520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33992263 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue techniques (mobilization, taping, and stretching) targeting lower limb range of motion (LLROM)
Number of subjects: 8
Study 34965171 — intervention group
Group type: EXPERIMENTAL
Intervention: CT imaging
Number of subjects: 54
Study 34965171 — intervention group
Group type: COMPARATOR
Intervention: MRI imaging
Number of subjects: 54
Study 33941219 — intervention group
Group type: EXPERIMENTAL
Intervention: Hylan G‐F 20
Number of subjects: 40
Study 33941219 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (Control Group)
Number of subjects: 40
Study 35108670 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin skin grafting (UTSG)
Number of subjects: 52
Study 35108670 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressing
Number of subjects: 52
Study 34971285 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation group (TG) - 6-week motor-cognitive dual-task exercise training performed online under supervision.
Number of subjects: 18
Study 34971285 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - No physical or cognitive intervention for 6 weeks.
Number of subjects: 18
Study 34073590 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time OEP phase angle and volume feedback system
Number of subjects: 18
Study 34073590 — intervention group
Group type: COMPARATOR
Intervention: Real-time OEP volume feedback alone
Number of subjects: 18
Study 32076718 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive therapy
Number of subjects: 160
Study 32076718 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis therapy
Number of subjects: 160
Study 32076718 — intervention group
Group type: EXPERIMENTAL
Intervention: Fifteen-day CMI risk stratification
Number of subjects: 160
Study 616191741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Practitioner (NP) assessment
Number of subjects: 235
Study 616191741 — intervention group
Group type: COMPARATOR
Intervention: Radiation Oncologist (RO) assessment
Number of subjects: 235
Study 35128952 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being apps usage
Number of subjects: 0
Study 34202464 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic association study using ABO-associated genetic variants as instrumental variables
Number of subjects: 1008
Study 34202464 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) studies on blood pressures
Number of subjects: 1008
Study 34202464 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) studies on severe COVID-19 with respiratory failure
Number of subjects: 1008
Study 32370930 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + BA + CM
Number of subjects: 180
Study 32370930 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking Abstinence
Number of subjects: 180
Study 32370930 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in Depressive Symptoms
Number of subjects: 180
Study 35715946 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 43522
Study 35715946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43522
Study 35715946 — intervention group
Group type: COMPARATOR
Intervention: DPP-4 inhibitors (including sitagliptin)
Number of subjects: 43522
Study 34424530 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine in alternating cycles with sapacitabine (study arm)
Number of subjects: 482
Study 34424530 — intervention group
Group type: COMPARATOR
Intervention: Decitabine monotherapy (control arm)
Number of subjects: 482
Study 34424530 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine in alternating cycles with sapacitabine (study arm) in patients with white blood cell counts <10 × 10^9 /L
Number of subjects: 482